RWAY Runway Growth Finance Corp.

BULLISH Impact: 7/10 PRESS-RELEASE
Horizon months Filed Apr 7, 2026 Processed 2mo ago Wire GlobeNewswire
Press release: m_and_a
Latest settled — T+20d
RWAY ▲ +2.53% at T+20d
LONG call ✓ call won +2.53% · α vs SPY -7.25% · entry $6.72 → $6.89
Next anchor: T+60d in 22d
Currently $5.96 · -11.31% from $6.72 entry
Entry anchored
Apr 6, 03:59 PM ET
via Databento tick
T+1d
-1.79%
call -1.79% · α -4.32%
$6.60
settled 2mo ago
T+5d
-3.42%
call -3.42% · α -8.75%
$6.49
settled 8w ago
T+20d
+2.53%
call +2.53% · α -7.25%
$6.89
settled 5w ago
T+60d
call — · α —
in 22d

Price Chart

Loading chart...

Executive Summary

Runway Growth Finance Corp. (RWAY) completed its $249 million acquisition of SWK Holdings Corporation, expanding its healthcare and life sciences exposure and scaling its platform. The deal, valued at $249.0 million in cash and stock, is expected to be accretive to earnings and increases RWAY's total assets to $1.2 billion on a pro forma basis. The company also announced $17.6 million in new fundings and leadership updates.

Key Financial Metrics

Deal Value
$249.0M

Actionable Insight

The acquisition enhances RWAY's scale and sector diversification, positioning it as a stronger player in venture lending. Traders should monitor future NII trends and dividend sustainability as integration progresses. The increased healthcare allocation may attract sector-focused investors.

Key Facts

  • Completed acquisition of SWK Holdings Corporation for $249.0 million ($173.5 million in cash, $75.5 million in shares valued at $11.93 NAV per share).
  • Runway Growth Capital LLC contributed an additional $9.0 million in cash to SWK stockholders outside the main transaction.
  • Pro forma total assets now stand at $1.2 billion.
  • Healthcare and life sciences exposure increased to 32% of portfolio from 14% as of December 31, 2025.
  • Funded $17.6 million in four investments during Q1 2026, including a $7.5 million investment in HR Pharmaceuticals.
  • CEO David Spreng resumed role as Chief Investment Officer.

Financial Impact

$249 million acquisition expands portfolio and scale; accretive to net investment income and dividend coverage.

total assetsportfolio diversificationearnings powerdividend coverage

Risk Factors

  • Integration risk from combining SWK's operations and portfolio.
  • Potential NAV volatility due to concentration in healthcare and life sciences.
  • Macroeconomic sensitivity in venture lending markets affecting credit quality.

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3269125
5 reports for RWAY
Performance horizon
Filters
Rows
Reports for RWAY — sortable, filterable
Type Now
May 6, 2026
4w ago
Press Release
NEUTRAL ★ 2/10
$6.81 $6.28▼ −7.78%▼ −10.56%$5.96 (−12.48%)
Apr 15, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$6.80 $6.66▼ −2.06%▼ −8.10%$5.96 (−12.35%)
Apr 7, 2026
9w ago
Press Release
BULLISH ★ 7/10
$6.72 $6.89▲ +2.53%▼ −7.25%$5.96 (−11.31%)
Mar 4, 2026
13w ago
EFFECT
NEUTRAL ★ 5/10
$7.74 $6.80▼ −12.16%▼ −7.75%$5.96 (−23.01%)
Feb 26, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$7.86 $6.81▼ −13.32%▼ −6.92%$5.96 (−24.14%)
Showing 5 of 5

US Market Status

Market Closed — Opens Thu (11h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access